Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02199548 · ClinicalTrials.gov registry record
The Good Patient Study
A clinical trial of Solid Tumor and Brain Tumor, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- 43
- Enrollment target
- 2
- Study locations
NCT02199548 is a study of Solid Tumor and Brain Tumor that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 43 participants, below the 221-participant average among 196 other Solid Tumor trials with a reported enrollment target (81% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT02199548, a study of Solid Tumor and Brain Tumor, has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
- 2
- Study locations
Study Summary
Adolescents with cancer weigh multiple influences in medical decision-making, including their own best interest, the perceived wishes of family members, and the interpreted preferences of the health care team. Parents of children with cancer often describe themselves as trying to be a good parent in making decisions in the child's best interest. Adolescents with cancer often describe themselves as trying to be a good patient and good child in making decisions in accord with how they believe a good patient and good child would decide. Among the challenges of caring for adolescents is the reality that the formative relational influences in adolescents' decision-making are both complex and unique due to adolescent patients' social networks and relational roles. Delineating adolescents' definitions of being a good patient, a good child, a good sibling, and a good friend may enable the care team to better understand the formative decisional influences relevant to adolescents with cancer. Expanding knowledge about the decision making constructs relevant to adolescents with cancer and recognizing the role of these social constructs in medical interactions has the potential for development of a comprehensive care model that methodically evaluates the self-assessed decision making influences and needs of adolescents at various stages in oncology care. This qualitative construct-defining study represents an initial step in the development of enhanced interventions for improved psychosocial support in this vulnerable population.
Conditions Studied
Interventions
- OTHER Interview
Study Locations (2)
District of Columbia
- Children's National Health System - Washington D.C.
Tennessee
- St. Jude Children's Research Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2014-07 |
| Est. Completion | 2015-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02199548
The ClinicalTrials.gov registry entry for NCT02199548 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 221-participant average among 196 other Solid Tumor trials with a reported enrollment target (81% lower). The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Solid Tumor appearing as the primary indexed condition, and to 1 intervention - of which Interview is the first listed.
NCT02199548 reports 2 study locations spanning 2 distinct geographic areas - top geographies include District of Columbia, Tennessee.
Frequently Asked Questions
What is clinical trial NCT02199548 about?
NCT02199548 is a clinical study titled "The Good Patient Study". Adolescents with cancer weigh multiple influences in medical decision-making, including their own best interest, the perceived wishes of family members, and the interpreted preferences of the health care team. Parents of children with cancer often describe themselves as trying to be a good parent in...
What is the current status of trial NCT02199548?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2014-07. Estimated completion is 2015-05.
What conditions does trial NCT02199548 study?
This clinical trial studies the following conditions: Solid Tumor, Brain Tumor, Hematological Malignancies.
What interventions are being tested in trial NCT02199548?
The interventions under investigation include: Interview (OTHER).
Who is sponsoring clinical trial NCT02199548?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02199548 being conducted?
This trial has 2 study locations across District of Columbia, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Solid Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors
RECRUITING · Phase 2
-
Dabrafenib and/or Trametinib Rollover Study
RECRUITING · Phase 4
-
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
RECRUITING · Phase 3
-
A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors
RECRUITING · Phase 1
-
Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.